Are Formulary Decision Makers Data Needs Being Met for Specialty Drugs?

This study targeted pharmacists and physicians involved with formulary decision making in order to assess the level of satisfaction of specialty drug formulary decision makers with regards to the strength of current available data sources and unmet needs regarding clinical, economic, and unpublished evidence. See more here. (Source: JMCP Volume 22 Issue (4), April 2016)

You might also be interested in:

eDossier System to Offer hēRo3 Model Integration November 8, 2018
ICER’s Updated Assessment of New Targeted Therapies for… June 13, 2018
ICER Releases Updated Report on Targeted Treatments for Plaque… August 5, 2018
ICER Publishes Guidance on Improving Development, Use of RWE… April 11, 2018
Report: RWE has Limited Use in Managed Care Formulary Decisions April 7, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
Real World Data Capabilities: Benchmarking Pharma Companies October 30, 2018